Active Ingredient
Aluminum sesquichlorohydrate 13.28%
Esika Winner Sport Antiperspirant Roll-on Deodorant Emulsion
FDA Label NDC 14141-365
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Bel Star S.a. for the product Esika Winner Sport Antiperspirant Roll-on Deodorant (NDC 14141-365). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, ask a doctor before use if you have, stop use if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Antiperspirant
Uses
- reduces underarm perspiration
Warnings
For external use only
Do Not Use
on broken skin
Ask A Doctor Before Use If You Have
kidney disease
Stop Use If
rash or irritation occurs
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply to underarms only
Inactive Ingredients
Water, steareth-2, ppg-15 stearyl ether, steareth-21, c13-15 alkane, fragrance, dicaprylyl carbonate, 2-methyl 5-cyclohexylpentanol, hydroxyacetophenone, tetrasodium edta, linalyl acetate, linalool, hexyl cinnamal, tetramethyl acetyloctahydronaphthalenes, citrus limon (lemon) peel oil, limonene, acetyl cedrene, amyl salicylate, pinene, benzyl salicylate, lavandula oil/extract, isoeugenol, coumarin, pogostemon cablin oil, citral, isoeugenyl acetate, geranyl acetate, eucalyptus globulus oil, citrus aurantium peel oil, benzyl benzoate, camphor, eugenol, geraniol, anethole, beta-caryophyllene.
Company Information
Dist. by Ventura Corp, Ltd., San Juan, Puerto Rico 00926.
Made in Colombia.
www.esika.com
Product Labeling
1 (Winner)
* Please review the disclaimer below.
